Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Camille Sarrazyn

3 Results

2021

Incidence, risk factors, timing and outcome of influenza versus Covid-19 associated putative invasive aspergillosis

Camille SarrazynSofie DhaeseBirgit DemeyStefaan VandecasteeleMarijke ReyndersJens Van Praet

A1 Journal Article in INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

2021

2019

Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial

Elke RammantPiet OstMartijn SwimbergheBarbara VanderstraetenNicolaas LumenKarel DecaesteckerRenée BultijnckGert De MeerleerCamille SarrazynRoos Colman et al.

A1 Journal Article in STRAHLENTHERAPIE UND ONKOLOGIE

2019

2018

4 Weeks versus 5 weeks of hypofractionated high-dose radiation therapy as primary therapy for prostate cancer : interim safety analysis of a randomized phase 3 trial

Valerie FonteyneCamille SarrazynMartijn SwimbergheGert De MeerleerElke RammantBarbara VanderstraetenFRANK VANPACHTENBEKENicolaas LumenKarel DecaesteckerRoos Colman et al.

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

2018